{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:12:21Z","timestamp":1790647941696,"version":"4.1.0"},"reference-count":109,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiac amyloidosis, encompassing both transthyretin (ATTR) and light-chain (AL) types, poses considerable challenges in patient management due to its intricate pathophysiology and progressive course. This narrative review elucidates the pivotal role of cardiopulmonary exercise testing (CPET) in the assessment of these patients. CPET is essential for evaluating disease progression by measuring cardio-respiratory performance and providing prognostic insights. This functional test is crucial not only for tracking the disease trajectory, but also for assessing the effectiveness of disease-modifying therapies. Moreover, CPET facilitates the customization of therapeutic strategies based on individual patient performance, enhancing personalized care. By objectively measuring parameters such as peak oxygen uptake (VO2 peak), ventilatory efficiency, and exercise capacity, clinicians can gain a deeper understanding of the degree of functional impairment and make informed decisions regarding treatment initiation, adjustment, and anticipated outcomes. This review emphasizes the importance of CPET in advancing personalized medicine approaches, ultimately striving to improve the quality of life and clinical outcomes for patients with cardiac amyloidosis.<\/jats:p>","DOI":"10.3390\/jcm13237285","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:48:56Z","timestamp":1733226536000},"page":"7285","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Advancing Cardiac Amyloidosis Care Through Insights from Cardiopulmonary Exercise Testing"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-0537","authenticated-orcid":false,"given":"Pietro","family":"Pugliatti","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9165-7732","authenticated-orcid":false,"given":"Giancarlo","family":"Trimarchi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy"},{"name":"Interdisciplinary Center for Health Sciences, Scuola Superiore Sant\u2019Anna, 56127 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1412-4747","authenticated-orcid":false,"given":"Federico","family":"Barocelli","sequence":"additional","affiliation":[{"name":"Cardiology Division, Parma University Hospital, 43126 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1053-8325","authenticated-orcid":false,"given":"Fausto","family":"Pizzino","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio, Ospedale del Cuore G, Pasquinucci, 54100 Massa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-9760","authenticated-orcid":false,"given":"Francesco","family":"Di Spigno","sequence":"additional","affiliation":[{"name":"Cardiology Unit of Emergency Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-3304","authenticated-orcid":false,"given":"Andrea","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"Cardiology Unit of Emergency Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio Cusm\u00e0","family":"Piccione","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangela","family":"Irrera","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1577-5402","authenticated-orcid":false,"given":"Daniela","family":"Aschieri","sequence":"additional","affiliation":[{"name":"Cardiology Unit of Emergency Department, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[{"name":"Cardiology Division, Parma University Hospital, 43126 Parma, Italy"},{"name":"Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-4732","authenticated-orcid":false,"given":"Umberto","family":"Paradossi","sequence":"additional","affiliation":[{"name":"Fondazione Toscana G. Monasterio, Ospedale del Cuore G, Pasquinucci, 54100 Massa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Di Bella","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Saito, Y., Nakamura, K., and Ito, H. (2022). Molecular Mechanisms of Cardiac Amyloidosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010025"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jcmg.2024.05.004","article-title":"Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain Amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchf.2020.12.005","article-title":"The Impact of Patients with Cardiac Amyloidosis in HFpEF Trials","volume":"9","author":"Oghina","year":"2021","journal-title":"JACC Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e011693","DOI":"10.1161\/CIRCHEARTFAILURE.123.011693","article-title":"Identifying the Mechanisms of a Peripherally Limited Exercise Phenotype in Patients with Heart Failure with Preserved Ejection Fraction","volume":"17","author":"Skow","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Juarez, M., Castillo-Rodriguez, C., Soliman, D., Del Rio-Pertuz, G., and Nugent, K. (2024). Cardiopulmonary Exercise Testing in Heart Failure. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11030070"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10741-013-9403-x","article-title":"Predicted Values of Exercise Capacity in Heart Failure: Where We Are, Where to Go","volume":"19","author":"Gargiulo","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The Mosaic of the Cardiac Amyloidosis Diagnosis: Role of Imaging in Subtypes and Stages of the Disease","volume":"15","author":"Pizzino","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pathol.2017.10.012","article-title":"Cardiac Amyloidosis: From Clinical Suspicion to Morphological Diagnosis","volume":"50","author":"Flodrova","year":"2018","journal-title":"Pathology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1177\/2047487319877708","article-title":"Keys to Early Diagnosis of Cardiac Amyloidosis: Red Flags from Clinical, Laboratory and Imaging Findings","volume":"27","author":"Vergaro","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.26965","article-title":"Amyloid Neuropathy: From Pathophysiology to Treatment in Light-Chain Amyloidosis and Hereditary Transthyretin Amyloidosis","volume":"96","author":"Chompoopong","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.3233\/JND-150091","article-title":"Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area","volume":"2","author":"Mazzeo","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hfc.2024.03.006","article-title":"Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update","volume":"20","author":"Monda","year":"2024","journal-title":"Heart Fail. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11886-019-1094-z","article-title":"Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging","volume":"21","author":"Recupero","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcmg.2023.10.010","article-title":"Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy","volume":"17","author":"Alwan","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1253\/circj.CJ-18-0816","article-title":"Myocardial Deformation Analysis and Late-Gadolinium Enhancement: Important Markers of Cardiac Amyloidosis Involvement That Can Masquerade as a False-Negative Diagnosis","volume":"82","author":"Pizzino","year":"2018","journal-title":"Circ. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCIMAGING.113.001478","article-title":"Letter by Di Bella et al Regarding Article, \u201cEffect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis from Other Causes of Concentric Left Ventricular Hypertrophy\u201d","volume":"7","author":"Pizzino","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/eurjpc\/zwab127","article-title":"A National Survey on Prevalence of Possible Echocardiographic Red Flags of Amyloid Cardiomyopathy in Consecutive Patients Undergoing Routine Echocardiography: Study Design and Patients Characterization\u2014The First Insight from the AC-TIVE Study","volume":"29","author":"Merlo","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/jcecho.jcecho_37_24","article-title":"Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review","volume":"34","author":"Trimarchi","year":"2024","journal-title":"J. Cardiovasc. Echogr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjcard.2023.09.055","article-title":"Myocardial Work Appraisal in Transthyretin Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy","volume":"208","author":"Trimarchi","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"de Gregorio, C., Trimarchi, G., Faro, D.C., Poleggi, C., Teresi, L., De Gaetano, F., Zito, C., Lofrumento, F., Koniari, I., and Licordari, R. (2024). Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction. J. Clin. Med., 13.","DOI":"10.20944\/preprints202403.0569.v1"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Laptseva, N., Rossi, V.A., Sudano, I., Schwotzer, R., Ruschitzka, F., Flammer, A.J., and Duru, F. (2023). Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072581"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mistrulli, R., Ferrera, A., Muthukkattil, M.L., Battistoni, A., Gallo, G., Barbato, E., Spera, F.R., and Magr\u00ec, D. (2024). Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020501"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.amjcard.2015.07.008","article-title":"Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects with Transthyretin Gene Mutation","volume":"116","author":"Minutoli","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Licordari, R., Trimarchi, G., Teresi, L., Restelli, D., Lofrumento, F., Perna, A., Campisi, M., de Gregorio, C., Grimaldi, P., and Calabr\u00f2, D. (2023). Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103481"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e08","DOI":"10.15420\/cfr.2022.26","article-title":"Role of Imaging in Cardiomyopathies","volume":"9","author":"Castiglione","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C130","DOI":"10.1093\/eurheartjsupp\/suad015","article-title":"Diagnostic and Prognostic Role of Late Gadolinium Enhancement in Cardiomyopathies","volume":"25","author":"Aquaro","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2017.06.085","article-title":"A Negative LGE Is Inconclusive to Exclude an Early Cardiac Amyloidosis: It\u2019s the Time for a T1 Mapping in Clinical Practice","volume":"247","author":"Pizzino","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, L., Zhu, J., Chen, M., Zhu, M., Dai, Y., and Hu, C. (2024). Prognostic Value of Native T1 and Extracellular Volume in Patients with Immunoglubin Light-Chain Amyloidosis. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-024-03756-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaccao.2022.08.009","article-title":"AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Wechalekar","year":"2022","journal-title":"JACC CardioOncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.hfc.2024.03.003","article-title":"The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis","volume":"20","author":"Morfino","year":"2024","journal-title":"Heart Fail. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2020.02.030","article-title":"Diphosphonate Single-Photon Emission Computed Tomography in Cardiac Transthyretin Amyloidosis","volume":"307","author":"Grigoratos","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Musetti, V., Greco, F., Castiglione, V., Aimo, A., Palmieri, C., Genovesi, D., Giorgetti, A., Emdin, M., Vergaro, G., and McDonnell, L.A. (2022). Tissue Characterization in Cardiac Amyloidosis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123054"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rognoni, P., Mazzini, G., Caminito, S., Palladini, G., and Lavatelli, F. (2021). Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics. Medicina, 57.","DOI":"10.3390\/medicina57090916"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Palstr\u00f8m, N.B., Rojek, A.M., M\u00f8ller, H.E.H., Hansen, C.T., Matthiesen, R., Rasmussen, L.M., Abildgaard, N., and Beck, H.C. (2022). Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010319"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.hfc.2024.03.001","article-title":"Clinical Use of Biomarkers in Cardiac Amyloidosis","volume":"20","author":"Lalario","year":"2024","journal-title":"Heart Fail. Clin."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac Troponin in Patients with Light Chain and Transthyretin Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Cipriani","year":"2024","journal-title":"JACC CardioOncol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4065\/mcp.2010.0480","article-title":"Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score","volume":"86","author":"Kumar","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaccao.2020.05.012","article-title":"Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients with Advanced AL Amyloidosis","volume":"2","author":"Drill","year":"2020","journal-title":"JACC CardioOncol"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ehf2.14710","article-title":"A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis","volume":"11","author":"Usuku","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Monte, I.P., Faro, D.C., Trimarchi, G., de Gaetano, F., Campisi, M., Losi, V., Teresi, L., Di Bella, G., Tamburino, C., and de Gregorio, C. (2023). Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10060261"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.21037\/cdt-23-205","article-title":"Early Diagnostic and Prognostic Value of Myocardial Strain Derived from Cardiovascular Magnetic Resonance in Patients with Cardiac Amyloidosis","volume":"13","author":"Hou","year":"2023","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"oead092","DOI":"10.1093\/ehjopen\/oead092","article-title":"Prognosis Prediction in Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging: A Systematic Review with Meta-Analysis","volume":"3","author":"Boretto","year":"2023","journal-title":"Eur. Heart J. Open"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Fuentes-Abolafio, I.J., Stubbs, B., P\u00e9rez-Belmonte, L.M., Bernal-L\u00f3pez, M.R., G\u00f3mez-Huelgas, R., and Cuesta-Vargas, A.I. (2020). Physical Functional Performance and Prognosis in Patients with Heart Failure: A Systematic Review and Meta-Analysis. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01725-5"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"C319","DOI":"10.1093\/eurheartjsupp\/suad057","article-title":"Cardiopulmonary Exercise Testing and Heart Failure: A Tale Born from Oxygen Uptake","volume":"25","author":"Mapelli","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jchf.2016.03.022","article-title":"Cardiopulmonary Exercise Testing in Heart Failure","volume":"4","author":"Malhotra","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of Heart Failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e006000","DOI":"10.1161\/JAHA.117.006000","article-title":"Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure with Reduced, Midrange, and Preserved Ejection Fraction","volume":"6","author":"Nadruz","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000164270.72123.18","article-title":"Peak Oxygen Consumption as a Predictor of Death in Patients with Heart Failure Receiving Beta-Blockers","volume":"111","author":"Young","year":"2005","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/eurheartj\/ehad141","article-title":"Heart Failure with Preserved Ejection Fraction: Relevance of a Dedicated Dyspnoea Clinic","volume":"44","author":"Verwerft","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e001121","DOI":"10.1136\/bmjresp-2021-001121","article-title":"ARTP Statement on Cardiopulmonary Exercise Testing 2021","volume":"8","author":"Pritchard","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIR.0b013e3181e52e69","article-title":"Clinician\u2019s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement from the American Heart Association","volume":"122","author":"Balady","year":"2010","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jacc.2015.11.050","article-title":"Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure","volume":"67","author":"Keteyian","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","article-title":"Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure with Preserved Ejection Fraction","volume":"6","author":"Reddy","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jchf.2020.03.008","article-title":"Impaired Exercise Tolerance in Heart Failure with Preserved Ejection Fraction: Quantification of Multiorgan System Reserve Capacity","volume":"8","author":"Nayor","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/ehf2.14070","article-title":"Peak O2-Pulse Predicts Exercise Training-Induced Changes in Peak VO2 in Heart Failure with Preserved Ejection Fraction","volume":"9","author":"Mueller","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"180101","DOI":"10.1183\/16000617.0101-2018","article-title":"ERS Statement on Standardisation of Cardiopulmonary Exercise Testing in Chronic Lung Diseases","volume":"28","author":"Radtke","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12931-022-02233-0","article-title":"Personalized Medicine Using Omics Approaches in Acute Respiratory Distress Syndrome to Identify Biological Phenotypes","volume":"23","author":"Battaglini","year":"2022","journal-title":"Respir. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12931-021-01895-6","article-title":"Practical Guide to Cardiopulmonary Exercise Testing in Adults","volume":"23","author":"Glaab","year":"2022","journal-title":"Respir. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"American Thoracic Society (2003). American College of Chest Physicians ATS\/ACCP Statement on Cardiopulmonary Exercise Testing. Am. J. Respir. Crit. Care Med., 167, 211\u2013277.","DOI":"10.1164\/rccm.167.2.211"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"qyad021","DOI":"10.1093\/ehjimp\/qyad021","article-title":"Combining Cardiopulmonary Exercise Testing with Echocardiography: A Multiparametric Approach to the Cardiovascular and Cardiopulmonary Systems","volume":"1","author":"Armenia","year":"2023","journal-title":"Eur. Heart J.-Imaging Methods Pract."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/clc.4960140317","article-title":"A Case of Cardiac Amyloidosis Presenting with Symptoms of Exertional Syncope","volume":"14","author":"Fujii","year":"1991","journal-title":"Clin. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/13506129.2018.1496077","article-title":"Peak V\u2019O2 Is an Independent Predictor of Survival in Patients with Cardiac Amyloidosis","volume":"25","author":"Hein","year":"2018","journal-title":"Amyloid"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e009974","DOI":"10.1161\/JAHA.118.009974","article-title":"Myocardial Oxygen Consumption and Efficiency in Patients with Cardiac Amyloidosis","volume":"7","author":"Clemmensen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0002-9149(99)00497-X","article-title":"Comparison of Usefulness between Exercise Capacity and Echocardiographic Indexes of Left Ventricular Function in Cardiac Amyloidosis","volume":"84","author":"Trikas","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clml.2021.03.015","article-title":"Cardiopulmonary Exercise Testing in Patients with Cardiac Amyloidosis","volume":"21","author":"Bhutani","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13506129.2019.1582024","article-title":"Chronotropic Incompetence and Autonomic Dysfunction as Mechanisms of Dyspnoea in Patients with Late Stage Cardiac Amyloidosis","volume":"26","author":"Stehlik","year":"2019","journal-title":"Amyloid"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ejhf.2016","article-title":"Prognostic Value of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis","volume":"23","author":"Nicol","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Banydeen, R., Monfort, A., Inamo, J., and Neviere, R. (2022). Diagnostic and Prognostic Values of Cardiopulmonary Exercise Testing in Cardiac Amyloidosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.898033"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Monfort, A., Thevenet, E., Lacavalerie, M.R., Banydeen, R., Inamo, J., and Neviere, R. (2022). Determinants of Ventilatory Inefficiency in Transthyretin Cardiac Amyloidosis: The Role of Excessive Ventilatory Drive. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.1002238"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2024.04.011","article-title":"Prognostic Value of a 6-Minute Walk Test in Patients with Transthyretin Cardiac Amyloidosis","volume":"84","author":"Ioannou","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.nmd.2018.11.002","article-title":"6MWT Performance Correlates with Peripheral Neuropathy but Not with Cardiac Involvement in Patients with Hereditary Transthyretin Amyloidosis (hATTR)","volume":"29","author":"Vita","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Luks, A.M., Glenny, R.W., and Robertson, H.T. (2013). Interpreting the Results of Cardiopulmonary Exercise Tests. Introduction to Cardiopulmonary Exercise Testing, Springer.","DOI":"10.1007\/978-1-4614-6283-5"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13506129.2020.1722098","article-title":"Restrictive Cardiac Phenotype as Primary Cause of Impaired Aerobic Capacity in Afro-Caribbean Patients with Val122ile Variant Transthyretin Amyloid Cardiomyopathy","volume":"27","author":"Monfort","year":"2020","journal-title":"Amyloid"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.899","article-title":"Inotropic Myocardial Reserve Deficiency Is the Predominant Feature of Exercise Haemodynamics in Cardiac Amyloidosis","volume":"19","author":"Clemmensen","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCHEARTFAILURE.109.910455","article-title":"Pressure-Volume Relationships in Patients with Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin: Transthyretin Cardiac Amyloid Study (TRACS)","volume":"4","author":"Bhuiyan","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cjca.2023.09.028","article-title":"Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients with Transthyretin Cardiac Amyloidosis","volume":"40","author":"Silverii","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"ref_80","first-page":"e008381","article-title":"Impact of Tafamidis and Optimal Background Treatment on Physical Performance in Patients with Transthyretin Amyloid Cardiomyopathy","volume":"15","author":"Rettl","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11897-024-00661-1","article-title":"(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis","volume":"21","author":"Wernhart","year":"2024","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Briasoulis, A., Theodorakakou, F., Rempakos, A., Petropoulos, I., Gavriatopoulou, M., Androulakis, E., Stamatelopoulos, K., Kallianos, A., Trakada, G., and Dimopoulos, M.A. (2022). Cardiopulmonary Exercise Physiology in AL Amyloidosis Patients with Cardiac Involvement and Its Association with Cardiac Imaging Parameters. JCM, 11.","DOI":"10.3390\/jcm11185437"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/ehf2.14406","article-title":"Cardiopulmonary Exercise Testing Predicts Prognosis in Amyloid Cardiomyopathy: A Systematic Review and Meta-analysis","volume":"10","author":"Cantone","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ahj.2010.08.037","article-title":"Prediction of Severe Cardiovascular Events by VE\/Vco2 Slope versus Peak Vo2 in Systolic Heart Failure: A Meta-Analysis of the Published Literature","volume":"160","author":"Poggio","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1700860","DOI":"10.1183\/13993003.00860-2017","article-title":"Ventilatory Response to Exercise in Cardiopulmonary Disease: The Role of Chemosensitivity and Dead Space","volume":"51","author":"Weatherald","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2019.03.035","article-title":"Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis","volume":"124","author":"Yunis","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cardfail.2006.10.018","article-title":"Pulmonary Function Changes Associated with Cardiomegaly in Chronic Heart Failure","volume":"13","author":"Olson","year":"2007","journal-title":"J. Card. Fail."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1253\/circj.CJ-20-1069","article-title":"Prevalence and Prognostic Significance of Pulmonary Function Test Abnormalities in Hospitalized Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction","volume":"85","author":"Kawakami","year":"2021","journal-title":"Circ. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1002\/ehf2.13342","article-title":"All-cause Mortality Predicted by Peak Oxygen Uptake Differs Depending on Spirometry Pattern in Patients with Heart Failure and Reduced Ejection Fraction","volume":"8","author":"Cho","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Banydeen, R., Eggleston, R., Deney, A., Monfort, A., Ryu, J.H., Vergaro, G., Castiglione, V., Lairez, O., Emdin, M., and Inamo, J. (2023). Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry. J. Clin. Med., 12.","DOI":"10.3390\/jcm12113684"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/13506129.2022.2052838","article-title":"Guidelines and New Directions in the Therapy and Monitoring of ATTRv Amyloidosis","volume":"29","author":"Ando","year":"2022","journal-title":"Amyloid"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11897-024-00669-7","article-title":"Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment","volume":"21","author":"Vogel","year":"2024","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Tomasoni, D., Bonfioli, G.B., Aimo, A., Adamo, M., Canepa, M., Inciardi, R.M., Lombardi, C.M., Nardi, M., Pagnesi, M., and Riccardi, M. (2023). Treating Amyloid Transthyretin Cardiomyopathy: Lessons Learned from Clinical Trials. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1154594"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Stelmach-Go\u0142dy\u015b, A., Zaborek-\u0141yczba, M., \u0141yczba, J., Garus, B., Pasiarski, M., Mertowska, P., Ma\u0142kowska, P., Hrynkiewicz, R., Nied\u017awiedzka-Rystwej, P., and Grywalska, E. (2022). Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis. JCM, 11.","DOI":"10.3390\/jcm11040911"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.46883\/ONC.2021.3508.0471","article-title":"The Role of Autologous Stem Cell Transplantation in Amyloidosis","volume":"35","author":"Vaxman","year":"2021","journal-title":"Oncology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/OP.22.00396","article-title":"Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of Therapeutic Innovation","volume":"19","author":"Dima","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-020-0306-5","article-title":"A Validated Composite Organ and Hematologic Response Model for Early Assessment of Treatment Outcomes in Light Chain Amyloidosis","volume":"10","author":"Sidana","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ehjci\/jeab226","article-title":"Tafamidis Treatment Delays Structural and Functional Changes of the Left Ventricle in Patients with Transthyretin Amyloid Cardiomyopathy","volume":"23","author":"Rettl","year":"2022","journal-title":"Eur. Heart J.-Cardiovasc. Imaging"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients with Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for Hereditary Transthyretin Amyloidosis with Polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cardfail.2021.06.022","article-title":"Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated with Tafamidis","volume":"27","author":"Dalia","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1536\/ihj.23-075","article-title":"Changes in Exercise Tolerance over Time in Patients with Transthyretin Amyloidosis Cardiomyopathy Treated with Tafamidis: A Preliminary Study","volume":"64","author":"Nakaya","year":"2023","journal-title":"Int. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 Inhibitor Therapy in Patients with Transthyretin Amyloid Cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jamacardio.2024.0022","article-title":"Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis","volume":"9","author":"Patel","year":"2024","journal-title":"JAMA Cardiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7285\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:43:09Z","timestamp":1760114589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":109,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13237285"],"URL":"https:\/\/doi.org\/10.3390\/jcm13237285","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}